TCL Archive Phase III Study: Rituxan Improved PFS By 79% In Advanced Follicular Lymphoma December 31, 2010Vol.33 No.12
TCL Archive ASCO Calls On NCI To Double Funding For Cooperative Group Clinical Trials December 31, 2010Vol.33 No.12
TCL Archive Tasigna Shows Benefit Over Gleevec In Phase III Study for Ph+ CML In Chronic Phase December 31, 2010Vol.33 No.12
TCL Archive Bosutinib Vs. Imatinib Study Didn’t Meet Primary Endpoint December 31, 2010Vol.33 No.12
TCL Archive Non-Adherence To Protocol Explains Outcome Differences In Hispanic Children With ALL December 31, 2010Vol.33 No.12
TCL Archive Afinitor Delayed Progression Compared To Tamoxifen Alone In Randomized Phase II Study December 31, 2010Vol.33 No.12
TCL Archive AZURE Trial: Zoledronic Acid Didn’t Improve DFS In Stage II/III December 31, 2010Vol.33 No.12
